RenovoRx, Inc. (RNXT) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "RNXT"
      ],
      "issuer_cik": "0001574094",
      "owner_cik": "0001207512",
      "accession_number": "0001493152-26-024726",
      "form_type": "4",
      "filing_date": "2026-05-21",
      "period_of_report": "2026-05-19",
      "issuer_name": "RenovoRx, Inc.",
      "issuer_trading_symbol": "RNXT",
      "owner_name": "VOLL MARK",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "Chief Financial Officer",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-05-19",
      "transaction_code": "P",
      "equity_swap_involved": false,
      "transaction_shares": 25000,
      "transaction_price_per_share": 0.7876,
      "transaction_acquired_disposed": "A",
      "shares_owned_following_transaction": 142380,
      "transaction_value": 19690,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "Reflects open market purchases of the Issuer's securities."
        },
        {
          "id": "F2",
          "description": "A grant of 58,953 restricted stock units (\"RSUs\") was previously reported for the Reporting Person's future service as the Chief Financial Officer of the Issuer, subject to monthly vesting with the RSUs valued based on the closing price on the last trading day of the month in which the services were performed. As of April 30, 2026, 8,823 of such RSUs had vested, leaving a remaining balance of 50,130 unvested RSUs."
        }
      ]
    },
    {
      "tickers": [
        "RNXT"
      ],
      "issuer_cik": "0001574094",
      "owner_cik": "0001862613",
      "accession_number": "0001493152-26-012482",
      "form_type": "4",
      "filing_date": "2026-03-24",
      "period_of_report": "2026-03-20",
      "issuer_name": "RenovoRx, Inc.",
      "issuer_trading_symbol": "RNXT",
      "owner_name": "Bagai Shaun",
      "is_director": true,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "Chief Executive Officer",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-03-20",
      "deemed_execution_date": "2026-03-20",
      "transaction_code": "P",
      "equity_swap_involved": false,
      "transaction_shares": 24300,
      "transaction_acquired_disposed": "A",
      "shares_owned_following_transaction": 313357,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "I",
      "nature_of_ownership": "The Bagai Family Trust",
      "footnotes": [
        {
          "id": "F1",
          "description": "The securities were purchased in a private placement on March 20, 2026 for an aggregate of $25,000."
        },
        {
          "id": "F3",
          "description": "289,057 shares of common stock are held of record by The Bagai Family Trust and were previously reported as \"directly\" beneficially held by the Reporting Person."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.